Monetary Management Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $31.6K | Hold |
250
| – | – | 0.01% | 292 |
|
|
2026
Q1 | $34.8K | Hold |
250
| – | – | 0.01% | 278 |
|
|
2025
Q4 | $30.7K | Hold |
250
| – | – | 0.01% | 285 |
|
|
2025
Q3 | $27.8K | Hold |
250
| – | – | 0.01% | 292 |
|
|
2025
Q2 | $27.7K | Hold |
250
| – | – | 0.01% | 288 |
|
|
2025
Q1 | $28K | Hold |
250
| – | – | 0.01% | 283 |
|
|
2024
Q4 | $23.1K | Hold |
250
| – | – | 0.01% | 297 |
|
|
2024
Q3 | $21K | Hold |
250
| – | – | 0.01% | 301 |
|
|
2024
Q2 | $17.2K | Hold |
250
| – | – | ﹤0.01% | 303 |
|
|
2024
Q1 | $18.3K | Hold |
250
| – | – | 0.01% | 304 |
|
|
2023
Q4 | $20.3K | Sell |
250
-500
| -67% | -$38.9K | 0.01% | 293 |
|
|
2023
Q3 | $56.2K | Hold |
750
| – | – | 0.02% | 240 |
|
|
2023
Q2 | $57.8K | Hold |
750
| – | – | 0.02% | 245 |
|
|
2023
Q1 | $62.2K | Hold |
750
| – | – | 0.02% | 241 |
|
|
2022
Q4 | $64.4K | Hold |
750
| – | – | 0.02% | 245 |
|
|
2022
Q3 | $46K | Hold |
750
| – | – | 0.02% | 261 |
|
|
2022
Q2 | $46K | Hold |
750
| – | – | 0.01% | 262 |
|
|
2022
Q1 | $45K | Hold |
750
| – | – | 0.01% | 279 |
|
|
2021
Q4 | $54K | Sell |
750
-3,500
| -82% | -$241K | 0.01% | 264 |
|
|
2021
Q3 | $297K | Buy |
4,250
+2,000
| +89% | +$141K | 0.08% | 163 |
|
|
2021
Q2 | $155K | Sell |
2,250
-500
| -18% | -$33.4K | 0.05% | 190 |
|
|
2021
Q1 | $178K | Buy |
2,750
+500
| +22% | +$32.2K | 0.06% | 178 |
|
|
2020
Q4 | $131K | Hold |
2,250
| – | – | 0.04% | 186 |
|
|
2020
Q3 | $142K | Hold |
2,250
| – | – | 0.05% | 171 |
|
|
2020
Q2 | $173K | Sell |
2,250
-100
| -4% | -$7.66K | 0.07% | 153 |
|
|
2020
Q1 | $176K | Sell |
2,350
-4,300
| -65% | -$297K | 0.08% | 143 |
|
|
2019
Q4 | $432K | Sell |
6,650
-750
| -10% | -$48.8K | 0.16% | 123 |
|
|
2019
Q3 | $469K | Buy |
7,400
+625
| +9% | +$40.9K | 0.18% | 117 |
|
|
2019
Q2 | $458K | Sell |
6,775
-4,700
| -41% | -$309K | 0.18% | 112 |
|
|
2019
Q1 | $746K | Hold |
11,475
| – | – | 0.3% | 89 |
|
|
2018
Q4 | $718K | Buy |
11,475
+250
| +2% | +$17.5K | 0.32% | 82 |
|
|
2018
Q3 | $867K | Buy |
11,225
+375
| +3% | +$28.3K | 0.33% | 77 |
|
|
2018
Q2 | $769K | Sell |
10,850
-950
| -8% | -$67.1K | 0.31% | 78 |
|
|
2018
Q1 | $890K | Sell |
11,800
-1,050
| -8% | -$83.5K | 0.37% | 71 |
|
|
2017
Q4 | $921K | Sell |
12,850
-14,145
| -52% | -$1.07M | 0.37% | 65 |
|
|
2017
Q3 | $2.19M | Sell |
26,995
-150
| -0.6% | -$11.5K | 0.92% | 34 |
|
|
2017
Q2 | $1.92M | Buy |
27,145
+975
| +4% | +$64.9K | 0.79% | 42 |
|
|
2017
Q1 | $1.78M | Sell |
26,170
-8,680
| -25% | -$610K | 0.77% | 45 |
|
|
2016
Q4 | $2.5M | Buy |
34,850
+510
| +1% | +$37.9K | 1.15% | 33 |
|
|
2016
Q3 | $2.72M | Sell |
34,340
-185
| -0.5% | -$15K | 1.26% | 29 |
|
|
2016
Q2 | $2.88M | Buy |
34,525
+1,460
| +4% | +$130K | 1.34% | 20 |
|
|
2016
Q1 | $3.04M | Sell |
33,065
-4,075
| -11% | -$367K | 1.48% | 13 |
|
|
2015
Q4 | $3.76M | Sell |
37,140
-1,155
| -3% | -$120K | 1.8% | 9 |
|
|
2015
Q3 | $3.76M | Sell |
38,295
-2,670
| -7% | -$297K | 1.88% | 6 |
|
|
2015
Q2 | $4.8M | Buy |
40,965
+3,555
| +10% | +$388K | 2.16% | 4 |
|
|
2015
Q1 | $3.67M | Buy |
37,410
+1,070
| +3% | +$109K | 1.62% | 12 |
|
|
2014
Q4 | $3.42M | Sell |
36,340
-50
| -0.1% | -$5.17K | 1.52% | 14 |
|
|
2014
Q3 | $3.87M | Sell |
36,390
-4,260
| -10% | -$417K | 1.8% | 5 |
|
|
2014
Q2 | $3.37M | Sell |
40,650
-6,325
| -13% | -$492K | 1.58% | 12 |
|
|
2014
Q1 | $3.33M | Buy |
46,975
+23,075
| +97% | +$1.81M | 1.55% | 12 |
|
|
2013
Q4 | $1.79M | Buy |
23,900
+10,700
| +81% | +$745K | 0.83% | 46 |
|
|
2013
Q3 | $830K | Buy |
13,200
+6,450
| +96% | +$385K | 0.44% | 71 |
|
|
2013
Q2 | $346K | Buy |
+6,750
| New | +$352K | 0.19% | 119 |
|
Other funds holding GILD
Monetary Management Group's GILD Position: Q2 2026 in Review
Monetary Management Group held its Gilead Sciences (GILD) position steady in Q2 2026 at 250 shares worth $31.6K. The position accounts for 0.01% of the portfolio, ranked #292.
Monetary Management Group first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.8M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Monetary Management Group held 250 shares of Gilead Sciences worth $31.6K as of Q2 2026.
- Monetary Management Group left its Gilead Sciences share count unchanged in Q2 2026.
- Gilead Sciences made up 0.01% of Monetary Management Group's portfolio in Q2 2026, its #292 holding.
- Monetary Management Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Monetary Management Group's Gilead Sciences position peaked at $4.8M in Q2 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Monetary Management Group's 13F filing for Q2 2026, filed 12 Aug 2026.